Success Stories: EB-1A Approved for a Research Assistant Professor in the Field of Biochemistry
We Received EB1-A (Alien of Extraordinary Ability) Approval on March 2nd, 2015 for a Research Assistant Professor in the Field of Biochemistry (Approval Notice)
Position at the Time of Case Filing: Research Assistant Professor
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Illinois
Approval Notice Date: March 2nd, 2015
Processing Time: 5 Months, 6 Days
In this case, the client that we had the pleasure of working with was a Research Assistant Professor from India in the field of Biochemistry. His specialized research has focused on vascular medicine and stem cell biology. His work had resulted in 18 peer-reviewed scientific articles and 24 presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 289 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also reviewed 28 manuscripts for at least 3 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “By conducting research that paves the way for the development of innovative treatment methods, [client] has facilitated the improved treatment for these health issues. In fact, in the wake of his study several scientific journals and pharmaceutical companies began to show a keen interest on STIM1 and its role in calcium homeostasis.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Biochemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 5 months and 6 days.

